Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-10-07

Clinical Trial Update: A Study of the Effect of Dulaglutide on the Action of Warfarin in Healthy Participants [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study to evaluate whether dulaglutide affects warfarin activity in healthy participants; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRULICITY (DULAGLUTIDE)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED | Results posted: 2014-10-07